Biocatalysis in Medicinal Chemistry: Challenges to Access and Drivers for Adoption
- PMID: 31620215
- PMCID: PMC6792145
- DOI: 10.1021/acsmedchemlett.9b00410
Biocatalysis in Medicinal Chemistry: Challenges to Access and Drivers for Adoption
Abstract
The use of biocatalysis in the manufacture of small molecule active pharmaceutical ingredients has seen a marked increase over the past decade. Driven by academic and industrial interest in the application of enzymes as catalysts for transforming chemical routes, the biocatalytic toolbox available to a chemist has continued to expand. Despite this, the application of biocatalysis in early discovery chemistry has trailed in comparison to its use in manufacturing routes. The authors offer their perspective on the adoption of biocatalysis in the early discovery space: highlighting challenges including enzyme supply and the biocatalysis business model, as well as recent trends that could spur more collaboration and access to enzymes for early discovery R&D activities.
Copyright © 2019 American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Hughes D. L. Biocatalysis in Drug Development—Highlights of the Recent Patent Literature. Org. Process Res. Dev. 2018, 22 (9), 1063–1080. 10.1021/acs.oprd.8b00232. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous